nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—SLCO1B3—Rosuvastatin—atherosclerosis	0.103	0.125	CbGbCtD
Rilpivirine—SLCO1B3—Pravastatin—atherosclerosis	0.094	0.114	CbGbCtD
Rilpivirine—SLCO1B1—Rosuvastatin—atherosclerosis	0.0602	0.0727	CbGbCtD
Rilpivirine—SLCO1B1—Ezetimibe—atherosclerosis	0.0602	0.0727	CbGbCtD
Rilpivirine—SLCO1B1—Simvastatin—atherosclerosis	0.0559	0.0676	CbGbCtD
Rilpivirine—SLCO1B1—Pravastatin—atherosclerosis	0.0547	0.0661	CbGbCtD
Rilpivirine—SLCO1B1—Lovastatin—atherosclerosis	0.0547	0.0661	CbGbCtD
Rilpivirine—ABCG2—Ezetimibe—atherosclerosis	0.0478	0.0578	CbGbCtD
Rilpivirine—ABCG2—Rosuvastatin—atherosclerosis	0.0478	0.0578	CbGbCtD
Rilpivirine—ABCG2—Pravastatin—atherosclerosis	0.0435	0.0525	CbGbCtD
Rilpivirine—CYP2B6—Simvastatin—atherosclerosis	0.0313	0.0378	CbGbCtD
Rilpivirine—CYP2C19—Rosuvastatin—atherosclerosis	0.0214	0.0258	CbGbCtD
Rilpivirine—CYP2C19—Simvastatin—atherosclerosis	0.0199	0.024	CbGbCtD
Rilpivirine—CYP2C19—Lovastatin—atherosclerosis	0.0194	0.0235	CbGbCtD
Rilpivirine—ABCB1—Ezetimibe—atherosclerosis	0.0172	0.0208	CbGbCtD
Rilpivirine—ABCB1—Simvastatin—atherosclerosis	0.016	0.0194	CbGbCtD
Rilpivirine—ABCB1—Lovastatin—atherosclerosis	0.0157	0.0189	CbGbCtD
Rilpivirine—ABCB1—Pravastatin—atherosclerosis	0.0157	0.0189	CbGbCtD
Rilpivirine—CYP3A4—Rosuvastatin—atherosclerosis	0.0103	0.0125	CbGbCtD
Rilpivirine—CYP3A4—Ezetimibe—atherosclerosis	0.0103	0.0125	CbGbCtD
Rilpivirine—CYP3A4—Simvastatin—atherosclerosis	0.0096	0.0116	CbGbCtD
Rilpivirine—CYP3A4—Lovastatin—atherosclerosis	0.0094	0.0114	CbGbCtD
Rilpivirine—CYP3A4—Pravastatin—atherosclerosis	0.0094	0.0114	CbGbCtD
Rilpivirine—High density lipoprotein decreased—Niacin—atherosclerosis	0.00682	0.0788	CcSEcCtD
Rilpivirine—Pazopanib—CSF1R—atherosclerosis	0.00405	1	CrCbGaD
Rilpivirine—Cholecystitis—Ezetimibe—atherosclerosis	0.00272	0.0314	CcSEcCtD
Rilpivirine—Transaminases increased—Lovastatin—atherosclerosis	0.00262	0.0303	CcSEcCtD
Rilpivirine—Transaminases increased—Ezetimibe—atherosclerosis	0.00257	0.0297	CcSEcCtD
Rilpivirine—Cholelithiasis—Ezetimibe—atherosclerosis	0.00251	0.029	CcSEcCtD
Rilpivirine—Transaminases increased—Simvastatin—atherosclerosis	0.00245	0.0283	CcSEcCtD
Rilpivirine—Transaminases increased—Pravastatin—atherosclerosis	0.00222	0.0256	CcSEcCtD
Rilpivirine—Cholelithiasis—Niacin—atherosclerosis	0.0022	0.0254	CcSEcCtD
Rilpivirine—Hepatotoxicity—Niacin—atherosclerosis	0.00177	0.0205	CcSEcCtD
Rilpivirine—Inflammation—Ezetimibe—atherosclerosis	0.00161	0.0186	CcSEcCtD
Rilpivirine—Sleep disorder—Rosuvastatin—atherosclerosis	0.00158	0.0182	CcSEcCtD
Rilpivirine—Inflammation—Simvastatin—atherosclerosis	0.00154	0.0178	CcSEcCtD
Rilpivirine—Sleep disorder—Simvastatin—atherosclerosis	0.00125	0.0144	CcSEcCtD
Rilpivirine—Sleep disorder—Pravastatin—atherosclerosis	0.00113	0.0131	CcSEcCtD
Rilpivirine—Depression—Rosuvastatin—atherosclerosis	0.00105	0.0121	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00102	0.0118	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.001	0.0116	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000995	0.0115	CcSEcCtD
Rilpivirine—Abdominal discomfort—Lovastatin—atherosclerosis	0.000959	0.0111	CcSEcCtD
Rilpivirine—Abdominal discomfort—Simvastatin—atherosclerosis	0.000897	0.0104	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000863	0.00997	CcSEcCtD
Rilpivirine—Depression—Simvastatin—atherosclerosis	0.000832	0.0096	CcSEcCtD
Rilpivirine—Mental disorder—Rosuvastatin—atherosclerosis	0.000828	0.00956	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000827	0.00955	CcSEcCtD
Rilpivirine—Depression—Pravastatin—atherosclerosis	0.000752	0.00868	CcSEcCtD
Rilpivirine—Immune system disorder—Ezetimibe—atherosclerosis	0.000709	0.00819	CcSEcCtD
Rilpivirine—Mental disorder—Ezetimibe—atherosclerosis	0.000688	0.00794	CcSEcCtD
Rilpivirine—Malnutrition—Ezetimibe—atherosclerosis	0.000684	0.00789	CcSEcCtD
Rilpivirine—Infection—Rosuvastatin—atherosclerosis	0.000667	0.0077	CcSEcCtD
Rilpivirine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000658	0.0076	CcSEcCtD
Rilpivirine—Mental disorder—Simvastatin—atherosclerosis	0.000656	0.00758	CcSEcCtD
Rilpivirine—Insomnia—Rosuvastatin—atherosclerosis	0.000607	0.00701	CcSEcCtD
Rilpivirine—Malnutrition—Niacin—atherosclerosis	0.000599	0.00691	CcSEcCtD
Rilpivirine—Anxiety—Lovastatin—atherosclerosis	0.000591	0.00683	CcSEcCtD
Rilpivirine—Dry mouth—Lovastatin—atherosclerosis	0.00058	0.0067	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000578	0.00667	CcSEcCtD
Rilpivirine—Dry mouth—Ezetimibe—atherosclerosis	0.000569	0.00657	CcSEcCtD
Rilpivirine—Infection—Lovastatin—atherosclerosis	0.000565	0.00653	CcSEcCtD
Rilpivirine—Infection—Ezetimibe—atherosclerosis	0.000554	0.0064	CcSEcCtD
Rilpivirine—Anxiety—Simvastatin—atherosclerosis	0.000553	0.00639	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000549	0.00634	CcSEcCtD
Rilpivirine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000547	0.00632	CcSEcCtD
Rilpivirine—Skin disorder—Ezetimibe—atherosclerosis	0.000542	0.00626	CcSEcCtD
Rilpivirine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000531	0.00613	CcSEcCtD
Rilpivirine—Infection—Simvastatin—atherosclerosis	0.000529	0.0061	CcSEcCtD
Rilpivirine—Insomnia—Lovastatin—atherosclerosis	0.000514	0.00594	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000506	0.00584	CcSEcCtD
Rilpivirine—Insomnia—Ezetimibe—atherosclerosis	0.000505	0.00583	CcSEcCtD
Rilpivirine—Anxiety—Pravastatin—atherosclerosis	0.0005	0.00577	CcSEcCtD
Rilpivirine—Dry mouth—Niacin—atherosclerosis	0.000498	0.00576	CcSEcCtD
Rilpivirine—Decreased appetite—Lovastatin—atherosclerosis	0.000494	0.00571	CcSEcCtD
Rilpivirine—Fatigue—Lovastatin—atherosclerosis	0.00049	0.00566	CcSEcCtD
Rilpivirine—Decreased appetite—Ezetimibe—atherosclerosis	0.000485	0.0056	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000482	0.00556	CcSEcCtD
Rilpivirine—Asthenia—Rosuvastatin—atherosclerosis	0.000482	0.00556	CcSEcCtD
Rilpivirine—Insomnia—Simvastatin—atherosclerosis	0.000481	0.00556	CcSEcCtD
Rilpivirine—Fatigue—Ezetimibe—atherosclerosis	0.000481	0.00555	CcSEcCtD
Rilpivirine—Infection—Pravastatin—atherosclerosis	0.000478	0.00552	CcSEcCtD
Rilpivirine—Skin disorder—Niacin—atherosclerosis	0.000475	0.00548	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000465	0.00537	CcSEcCtD
Rilpivirine—Decreased appetite—Simvastatin—atherosclerosis	0.000463	0.00534	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000459	0.0053	CcSEcCtD
Rilpivirine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000459	0.0053	CcSEcCtD
Rilpivirine—Fatigue—Simvastatin—atherosclerosis	0.000459	0.0053	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000456	0.00527	CcSEcCtD
Rilpivirine—Abdominal pain—Lovastatin—atherosclerosis	0.00045	0.00519	CcSEcCtD
Rilpivirine—Dizziness—Rosuvastatin—atherosclerosis	0.000444	0.00513	CcSEcCtD
Rilpivirine—Insomnia—Niacin—atherosclerosis	0.000442	0.0051	CcSEcCtD
Rilpivirine—Abdominal pain—Ezetimibe—atherosclerosis	0.000441	0.00509	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000435	0.00502	CcSEcCtD
Rilpivirine—Insomnia—Pravastatin—atherosclerosis	0.000435	0.00502	CcSEcCtD
Rilpivirine—Somnolence—Niacin—atherosclerosis	0.000434	0.00501	CcSEcCtD
Rilpivirine—Decreased appetite—Niacin—atherosclerosis	0.000425	0.0049	CcSEcCtD
Rilpivirine—Rash—Rosuvastatin—atherosclerosis	0.000423	0.00489	CcSEcCtD
Rilpivirine—Dermatitis—Rosuvastatin—atherosclerosis	0.000423	0.00488	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000422	0.00487	CcSEcCtD
Rilpivirine—Abdominal pain—Simvastatin—atherosclerosis	0.000421	0.00486	CcSEcCtD
Rilpivirine—Headache—Rosuvastatin—atherosclerosis	0.000421	0.00486	CcSEcCtD
Rilpivirine—Decreased appetite—Pravastatin—atherosclerosis	0.000418	0.00483	CcSEcCtD
Rilpivirine—Fatigue—Pravastatin—atherosclerosis	0.000415	0.00479	CcSEcCtD
Rilpivirine—Asthenia—Lovastatin—atherosclerosis	0.000408	0.00471	CcSEcCtD
Rilpivirine—Asthenia—Ezetimibe—atherosclerosis	0.0004	0.00462	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Niacin—atherosclerosis	0.0004	0.00461	CcSEcCtD
Rilpivirine—Nausea—Rosuvastatin—atherosclerosis	0.000399	0.0046	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000393	0.00454	CcSEcCtD
Rilpivirine—Diarrhoea—Lovastatin—atherosclerosis	0.000389	0.00449	CcSEcCtD
Rilpivirine—Abdominal pain—Niacin—atherosclerosis	0.000386	0.00446	CcSEcCtD
Rilpivirine—Asthenia—Simvastatin—atherosclerosis	0.000382	0.00441	CcSEcCtD
Rilpivirine—Diarrhoea—Ezetimibe—atherosclerosis	0.000382	0.00441	CcSEcCtD
Rilpivirine—Abdominal pain—Pravastatin—atherosclerosis	0.00038	0.00439	CcSEcCtD
Rilpivirine—Dizziness—Lovastatin—atherosclerosis	0.000376	0.00434	CcSEcCtD
Rilpivirine—Dizziness—Ezetimibe—atherosclerosis	0.000369	0.00426	CcSEcCtD
Rilpivirine—Diarrhoea—Simvastatin—atherosclerosis	0.000364	0.0042	CcSEcCtD
Rilpivirine—Vomiting—Lovastatin—atherosclerosis	0.000362	0.00418	CcSEcCtD
Rilpivirine—Rash—Lovastatin—atherosclerosis	0.000359	0.00414	CcSEcCtD
Rilpivirine—Dermatitis—Lovastatin—atherosclerosis	0.000358	0.00414	CcSEcCtD
Rilpivirine—Headache—Lovastatin—atherosclerosis	0.000356	0.00411	CcSEcCtD
Rilpivirine—Vomiting—Ezetimibe—atherosclerosis	0.000355	0.0041	CcSEcCtD
Rilpivirine—Dizziness—Simvastatin—atherosclerosis	0.000352	0.00406	CcSEcCtD
Rilpivirine—Rash—Ezetimibe—atherosclerosis	0.000352	0.00406	CcSEcCtD
Rilpivirine—Dermatitis—Ezetimibe—atherosclerosis	0.000351	0.00406	CcSEcCtD
Rilpivirine—Asthenia—Niacin—atherosclerosis	0.000351	0.00405	CcSEcCtD
Rilpivirine—Headache—Ezetimibe—atherosclerosis	0.00035	0.00404	CcSEcCtD
Rilpivirine—Asthenia—Pravastatin—atherosclerosis	0.000345	0.00399	CcSEcCtD
Rilpivirine—Vomiting—Simvastatin—atherosclerosis	0.000338	0.00391	CcSEcCtD
Rilpivirine—Nausea—Lovastatin—atherosclerosis	0.000338	0.0039	CcSEcCtD
Rilpivirine—Rash—Simvastatin—atherosclerosis	0.000335	0.00387	CcSEcCtD
Rilpivirine—Dermatitis—Simvastatin—atherosclerosis	0.000335	0.00387	CcSEcCtD
Rilpivirine—Diarrhoea—Niacin—atherosclerosis	0.000334	0.00386	CcSEcCtD
Rilpivirine—Headache—Simvastatin—atherosclerosis	0.000333	0.00385	CcSEcCtD
Rilpivirine—Nausea—Ezetimibe—atherosclerosis	0.000331	0.00383	CcSEcCtD
Rilpivirine—Diarrhoea—Pravastatin—atherosclerosis	0.000329	0.0038	CcSEcCtD
Rilpivirine—Dizziness—Niacin—atherosclerosis	0.000323	0.00373	CcSEcCtD
Rilpivirine—Dizziness—Pravastatin—atherosclerosis	0.000318	0.00367	CcSEcCtD
Rilpivirine—Nausea—Simvastatin—atherosclerosis	0.000316	0.00365	CcSEcCtD
Rilpivirine—Vomiting—Niacin—atherosclerosis	0.000311	0.00359	CcSEcCtD
Rilpivirine—Rash—Niacin—atherosclerosis	0.000308	0.00356	CcSEcCtD
Rilpivirine—Dermatitis—Niacin—atherosclerosis	0.000308	0.00355	CcSEcCtD
Rilpivirine—Headache—Niacin—atherosclerosis	0.000306	0.00353	CcSEcCtD
Rilpivirine—Vomiting—Pravastatin—atherosclerosis	0.000306	0.00353	CcSEcCtD
Rilpivirine—Rash—Pravastatin—atherosclerosis	0.000303	0.0035	CcSEcCtD
Rilpivirine—Dermatitis—Pravastatin—atherosclerosis	0.000303	0.0035	CcSEcCtD
Rilpivirine—Headache—Pravastatin—atherosclerosis	0.000301	0.00348	CcSEcCtD
Rilpivirine—Nausea—Niacin—atherosclerosis	0.00029	0.00335	CcSEcCtD
Rilpivirine—Nausea—Pravastatin—atherosclerosis	0.000286	0.0033	CcSEcCtD
Rilpivirine—SLCO1B3—Metabolism—PPARG—atherosclerosis	1.5e-05	0.000183	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.49e-05	0.000183	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALOX15—atherosclerosis	1.49e-05	0.000183	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOA2—atherosclerosis	1.49e-05	0.000183	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.49e-05	0.000183	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CETP—atherosclerosis	1.48e-05	0.000181	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCG5—atherosclerosis	1.47e-05	0.00018	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—INS—atherosclerosis	1.47e-05	0.00018	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.46e-05	0.000179	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.46e-05	0.000179	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LPA—atherosclerosis	1.46e-05	0.000179	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOB—atherosclerosis	1.44e-05	0.000177	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.44e-05	0.000176	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LPA—atherosclerosis	1.42e-05	0.000174	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.42e-05	0.000173	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—BGN—atherosclerosis	1.41e-05	0.000173	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—FABP4—atherosclerosis	1.41e-05	0.000173	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LCAT—atherosclerosis	1.41e-05	0.000173	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—atherosclerosis	1.4e-05	0.000172	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.4e-05	0.000172	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOA5—atherosclerosis	1.4e-05	0.000171	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—HMOX1—atherosclerosis	1.39e-05	0.000171	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA4—atherosclerosis	1.38e-05	0.000169	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—BGN—atherosclerosis	1.38e-05	0.000169	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—LPL—atherosclerosis	1.38e-05	0.000169	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOA5—atherosclerosis	1.36e-05	0.000167	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—atherosclerosis	1.36e-05	0.000167	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.36e-05	0.000166	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.36e-05	0.000166	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—atherosclerosis	1.35e-05	0.000165	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.34e-05	0.000165	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000165	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.34e-05	0.000164	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOB—atherosclerosis	1.34e-05	0.000164	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.33e-05	0.000163	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.32e-05	0.000161	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.31e-05	0.000161	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.31e-05	0.000161	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CD36—atherosclerosis	1.31e-05	0.00016	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.3e-05	0.000159	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—atherosclerosis	1.3e-05	0.000159	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.000159	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.29e-05	0.000159	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NOS3—atherosclerosis	1.29e-05	0.000158	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—LPL—atherosclerosis	1.28e-05	0.000156	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALOX5—atherosclerosis	1.27e-05	0.000155	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.26e-05	0.000154	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GPX1—atherosclerosis	1.24e-05	0.000152	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MTHFR—atherosclerosis	1.24e-05	0.000152	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.24e-05	0.000151	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.22e-05	0.000149	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARA—atherosclerosis	1.22e-05	0.000149	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CD36—atherosclerosis	1.21e-05	0.000148	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.21e-05	0.000148	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.2e-05	0.000147	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.19e-05	0.000146	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AGT—atherosclerosis	1.18e-05	0.000144	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—atherosclerosis	1.18e-05	0.000144	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.18e-05	0.000144	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.17e-05	0.000144	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.16e-05	0.000143	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.16e-05	0.000142	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOE—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MTHFR—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CAV1—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOA1—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NAMPT—atherosclerosis	1.14e-05	0.000139	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LPA—atherosclerosis	1.14e-05	0.000139	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LIPC—atherosclerosis	1.13e-05	0.000138	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARA—atherosclerosis	1.13e-05	0.000138	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOC3—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CETP—atherosclerosis	1.12e-05	0.000137	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LDLR—atherosclerosis	1.12e-05	0.000137	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—BGN—atherosclerosis	1.1e-05	0.000135	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.09e-05	0.000134	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AGT—atherosclerosis	1.09e-05	0.000134	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CETP—atherosclerosis	1.09e-05	0.000134	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.09e-05	0.000133	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CAV1—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOA1—atherosclerosis	1.06e-05	0.000129	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.05e-05	0.000128	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.05e-05	0.000128	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SCARB1—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.04e-05	0.000127	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.03e-05	0.000126	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—atherosclerosis	1.01e-05	0.000123	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—INS—atherosclerosis	9.86e-06	0.000121	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HMGCR—atherosclerosis	9.86e-06	0.000121	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOB—atherosclerosis	9.79e-06	0.00012	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.69e-06	0.000119	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.66e-06	0.000118	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—atherosclerosis	9.65e-06	0.000118	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—atherosclerosis	9.52e-06	0.000117	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.35e-06	0.000115	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—LPL—atherosclerosis	9.35e-06	0.000115	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—atherosclerosis	9.31e-06	0.000114	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.19e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.19e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA2—atherosclerosis	9.19e-06	0.000113	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.19e-06	0.000113	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—INS—atherosclerosis	9.13e-06	0.000112	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GPX1—atherosclerosis	9.12e-06	0.000112	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.11e-06	0.000112	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.08e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.07e-06	0.000111	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—atherosclerosis	9.04e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.02e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LIPC—atherosclerosis	9.02e-06	0.000111	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCA1—atherosclerosis	9e-06	0.00011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOC3—atherosclerosis	8.96e-06	0.00011	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LDLR—atherosclerosis	8.91e-06	0.000109	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CD36—atherosclerosis	8.88e-06	0.000109	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCA1—atherosclerosis	8.79e-06	0.000108	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LPA—atherosclerosis	8.76e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CETP—atherosclerosis	8.7e-06	0.000107	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NOS3—atherosclerosis	8.65e-06	0.000106	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—BGN—atherosclerosis	8.49e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.42e-06	0.000103	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.4e-06	0.000103	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—atherosclerosis	8.37e-06	0.000103	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.33e-06	0.000102	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARA—atherosclerosis	8.26e-06	0.000101	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.11e-06	9.94e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.09e-06	9.91e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NOS3—atherosclerosis	8.01e-06	9.81e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AGT—atherosclerosis	8e-06	9.8e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—atherosclerosis	7.91e-06	9.69e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.87e-06	9.64e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—atherosclerosis	7.84e-06	9.6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.81e-06	9.57e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CAV1—atherosclerosis	7.76e-06	9.51e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOA1—atherosclerosis	7.75e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HMOX1—atherosclerosis	7.72e-06	9.46e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HMOX1—atherosclerosis	7.54e-06	9.24e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOB—atherosclerosis	7.4e-06	9.06e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—atherosclerosis	7.32e-06	8.97e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOB—atherosclerosis	7.22e-06	8.85e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.2e-06	8.82e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.1e-06	8.7e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.07e-06	8.66e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—LPL—atherosclerosis	7.06e-06	8.65e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—atherosclerosis	7.02e-06	8.61e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.01e-06	8.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.01e-06	8.58e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.96e-06	8.53e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.92e-06	8.48e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—LPL—atherosclerosis	6.89e-06	8.45e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GPX1—atherosclerosis	6.89e-06	8.44e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.88e-06	8.42e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—atherosclerosis	6.83e-06	8.36e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GPX1—atherosclerosis	6.73e-06	8.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CETP—atherosclerosis	6.72e-06	8.23e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CD36—atherosclerosis	6.71e-06	8.22e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—INS—atherosclerosis	6.69e-06	8.2e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CD36—atherosclerosis	6.55e-06	8.03e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.43e-06	7.88e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.36e-06	7.79e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARA—atherosclerosis	6.24e-06	7.65e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—atherosclerosis	6.21e-06	7.61e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—atherosclerosis	6.14e-06	7.52e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARA—atherosclerosis	6.09e-06	7.46e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.07e-06	7.44e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AGT—atherosclerosis	6.04e-06	7.4e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.02e-06	7.37e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—atherosclerosis	5.92e-06	7.25e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—atherosclerosis	5.92e-06	7.25e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AGT—atherosclerosis	5.9e-06	7.23e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NOS3—atherosclerosis	5.87e-06	7.19e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CAV1—atherosclerosis	5.87e-06	7.19e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOA1—atherosclerosis	5.85e-06	7.17e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—atherosclerosis	5.78e-06	7.08e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOB—atherosclerosis	5.76e-06	7.06e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CAV1—atherosclerosis	5.73e-06	7.02e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOA1—atherosclerosis	5.71e-06	7e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.61e-06	6.87e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—LPL—atherosclerosis	5.5e-06	6.74e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.41e-06	6.63e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GPX1—atherosclerosis	5.37e-06	6.58e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.37e-06	6.58e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.34e-06	6.55e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CD36—atherosclerosis	5.23e-06	6.41e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.22e-06	6.39e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—atherosclerosis	5.16e-06	6.32e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—INS—atherosclerosis	5.06e-06	6.2e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—atherosclerosis	5.03e-06	6.17e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.96e-06	6.07e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—INS—atherosclerosis	4.94e-06	6.05e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARA—atherosclerosis	4.86e-06	5.96e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AGT—atherosclerosis	4.71e-06	5.77e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.64e-06	5.69e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—atherosclerosis	4.64e-06	5.68e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—atherosclerosis	4.61e-06	5.65e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CAV1—atherosclerosis	4.57e-06	5.6e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOA1—atherosclerosis	4.56e-06	5.59e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—atherosclerosis	4.53e-06	5.55e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOB—atherosclerosis	4.45e-06	5.45e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NOS3—atherosclerosis	4.44e-06	5.44e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NOS3—atherosclerosis	4.33e-06	5.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.33e-06	5.3e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—LPL—atherosclerosis	4.25e-06	5.2e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.16e-06	5.1e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.14e-06	5.08e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.06e-06	4.97e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CD36—atherosclerosis	4.04e-06	4.95e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.02e-06	4.92e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—atherosclerosis	3.98e-06	4.87e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—atherosclerosis	3.96e-06	4.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—INS—atherosclerosis	3.94e-06	4.83e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.82e-06	4.69e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.75e-06	4.6e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—atherosclerosis	3.68e-06	4.51e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AGT—atherosclerosis	3.63e-06	4.45e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—atherosclerosis	3.61e-06	4.43e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—atherosclerosis	3.56e-06	4.36e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.53e-06	4.32e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.52e-06	4.31e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.46e-06	4.23e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.21e-06	3.94e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.16e-06	3.87e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.1e-06	3.8e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—INS—atherosclerosis	3.04e-06	3.73e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—atherosclerosis	2.79e-06	3.42e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—atherosclerosis	2.7e-06	3.31e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.67e-06	3.27e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.44e-06	2.99e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.04e-06	2.5e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—atherosclerosis	1.99e-06	2.44e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.59e-06	1.95e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.23e-06	1.5e-05	CbGpPWpGaD
